12885_2020_7100_MOESM4_ESM.xlsx (54.08 kB)
Additional file 4 of Candidate methylation sites associated with endocrine therapy resistance in ER+/HER2- breast cancer
dataset
posted on 2020-07-20, 04:04 authored by Maryam Soleimani Dodaran, Simone Borgoni, Emre Sofyalı, Pernette J. Verschure, Stefan Wiemann, Perry D. Moerland, Antoine H. C. van KampenAdditional file 4. Single-locus survival analysis. Results of single-locus survival analysis on ER+/HER2-, TAM and AI cohorts. For each CpG the results of the correlation analysis and of the differential methylation analysis of month 7 versus WT in the T47D RA experiment are also included.